Circulating Tumor DNA in Surgical Lung Cancer Patients
NCT03081741 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2017-05-23
Summary
Conduct a prospective study to detect the change of ctDNA of surgical lung cancer patients.
Conditions
- Lung Neoplasms
Sponsors & Collaborators
-
Shenzhen People's Hospital
collaborator OTHER -
Shenzhen Second People's Hospital
collaborator OTHER -
Peking University Shenzhen Hospital
collaborator OTHER -
Shenzhen Gene Health Bio Tech Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Geng Tian, MD · Shenzhen Second People's Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-03
- Primary Completion
- 2017-12-01
- Completion
- 2020-03-18
Countries
- China
Study Locations
More Related Trials
-
Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA
NCT02833467 ·Status: UNKNOWN
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS
NCT03465241 ·Status: COMPLETED
-
Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
NCT02804100 ·Status: UNKNOWN
-
Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).
NCT03634826 ·Status: UNKNOWN
-
Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung Cancer
NCT03317080 ·Status: UNKNOWN
-
Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
NCT03664843 ·Status: UNKNOWN
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study
NCT02907606 ·Status: UNKNOWN
-
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
NCT06477211 ·Status: COMPLETED
-
Preoperative and Postoperative ctDNA Comparison in Early Stage Lung Cancer
NCT03805256 ·Status: UNKNOWN
-
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121 ·Status: UNKNOWN
-
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
NCT03320044 ·Status: COMPLETED
-
Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following Resection
NCT04238130 ·Status: COMPLETED
-
Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients
NCT03685669 ·Status: UNKNOWN
-
Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
NCT03090815 ·Status: UNKNOWN
-
The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor
NCT04405557 ·Status: ACTIVE_NOT_RECRUITING
-
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102 ·Status: TERMINATED
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients
NCT05023746 ·Status: COMPLETED
-
ctDNA as a Biomarker for Treatment in Advanced NSCLC
NCT05486988 ·Status: UNKNOWN
-
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy
NCT05822284 ·Status: NOT_YET_RECRUITING
-
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
NCT06358222 ·Status: RECRUITING
-
NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy
NCT04636047 ·Status: UNKNOWN
-
Detection Cell Free DNA in Lung Cancer Patients
NCT02738593 ·Status: UNKNOWN